University of Tasmania
Browse

File(s) under permanent embargo

Stem cells and regenerative medicine: From research to clinical applications

journal contribution
posted on 2023-05-17, 18:43 authored by Donald ChalmersDonald Chalmers, Rathjen, P, Rathjen, J, Dianne NicolDianne Nicol
Stem cell science has attracted widespread international interest in recent years. Stem cells are valuable tools for basic science. There are considerable hopes that stem cell technology may lead to treatments for degenerative diseases such as Parkinson's disease, and for ischemic events, such as stroke and heart attack. Stem cells may become sources for replacement and transplantation tissue for nerve, muscle, blood, liver, pancreatic and heart diseases. The science has accelerated over the last decade, especially since the discovery of pluripotent embryonic stem (ES) cells in humans in 1998. The term "regenerative medicine" is increasingly used as stem cell research moves towards clinical applications, such as trials to address macular degenerative disorders. This article examines the current state of the science of stem cell technology, the regulatory frameworks established for the derivation of stem cells, particularly from human embryos, which has attracted the greatest ethical and legal controversy, and the translation of stem cell research to clinical applications.

History

Publication title

Journal of Law and Medicine

Volume

20

Issue

4

Pagination

831-844

ISSN

1320-159X

Department/School

Faculty of Law

Publisher

Thomson Reuters

Place of publication

Pyrmont

Rights statement

Copyright 2013 Thomson Reuters

Repository Status

  • Restricted

Socio-economic Objectives

Justice and the law not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC